[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Prostacyclin Analogs Market Research Report 2016

August 2016 | 107 pages | ID: G5BC7D8C687EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Production, means the output of Prostacyclin Analogs

Revenue, means the sales value of Prostacyclin Analogs

This report studies Prostacyclin Analogs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
  • Actelion Pharmaceuticals Ltd.
  • United Therapeutics Corporation
  • Gilead sciences
  • Bayer AG
  • SteadyMed Ltd.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Reata Pharmaceuticals Inc.
  • Arena Pharmaceuticals Inc.
  • Merck & Co. Inc
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Prostacyclin Analogs in these regions, from 2011 to 2021 (forecast), like
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on consumption, market share and growth rate of Prostacyclin Analogs in each application, can be divided into
  • Health care
  • Clinic
  • Hospital
Global Prostacyclin Analogs Market Research Report 2016

1 PROSTACYCLIN ANALOGS MARKET OVERVIEW

1.1 Product Overview and Scope of Prostacyclin Analogs
1.2 Prostacyclin Analogs Segment by Type
  1.2.1 Global Production Market Share of Prostacyclin Analogs by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Prostacyclin Analogs Segment by Application
  1.3.1 Prostacyclin Analogs Consumption Market Share by Application in 2015
  1.3.2 Health care
  1.3.3 Clinic
  1.3.4 Hospital
1.4 Prostacyclin Analogs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Prostacyclin Analogs (2011-2021)

2 GLOBAL PROSTACYCLIN ANALOGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Prostacyclin Analogs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Prostacyclin Analogs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Prostacyclin Analogs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Prostacyclin Analogs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Prostacyclin Analogs Market Competitive Situation and Trends
  2.5.1 Prostacyclin Analogs Market Concentration Rate
  2.5.2 Prostacyclin Analogs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL PROSTACYCLIN ANALOGS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Prostacyclin Analogs Production and Market Share by Region (2011-2016)
3.2 Global Prostacyclin Analogs Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL PROSTACYCLIN ANALOGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Prostacyclin Analogs Consumption by Regions (2011-2016)
4.2 North America Prostacyclin Analogs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Prostacyclin Analogs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Prostacyclin Analogs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Prostacyclin Analogs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Prostacyclin Analogs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Prostacyclin Analogs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL PROSTACYCLIN ANALOGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Prostacyclin Analogs Production and Market Share by Type (2011-2016)
5.2 Global Prostacyclin Analogs Revenue and Market Share by Type (2011-2016)
5.3 Global Prostacyclin Analogs Price by Type (2011-2016)
5.4 Global Prostacyclin Analogs Production Growth by Type (2011-2016)

6 GLOBAL PROSTACYCLIN ANALOGS MARKET ANALYSIS BY APPLICATION

6.1 Global Prostacyclin Analogs Consumption and Market Share by Application (2011-2016)
6.2 Global Prostacyclin Analogs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL PROSTACYCLIN ANALOGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Actelion Pharmaceuticals Ltd.
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Prostacyclin Analogs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Actelion Pharmaceuticals Ltd. Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 United Therapeutics Corporation
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Prostacyclin Analogs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 United Therapeutics Corporation Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Gilead sciences
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Prostacyclin Analogs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Gilead sciences Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Bayer AG
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Prostacyclin Analogs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Bayer AG Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 SteadyMed Ltd.
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Prostacyclin Analogs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 SteadyMed Ltd. Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 GlaxoSmithKline plc
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Prostacyclin Analogs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 GlaxoSmithKline plc Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Pfizer Inc.
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Prostacyclin Analogs Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Pfizer Inc. Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Reata Pharmaceuticals Inc.
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Prostacyclin Analogs Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Reata Pharmaceuticals Inc. Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Arena Pharmaceuticals Inc.
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Prostacyclin Analogs Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Arena Pharmaceuticals Inc. Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Merck & Co. Inc
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Prostacyclin Analogs Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Merck & Co. Inc Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview

8 PROSTACYCLIN ANALOGS MANUFACTURING COST ANALYSIS

8.1 Prostacyclin Analogs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Prostacyclin Analogs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Prostacyclin Analogs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Prostacyclin Analogs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PROSTACYCLIN ANALOGS MARKET FORECAST (2016-2021)

12.1 Global Prostacyclin Analogs Production, Revenue Forecast (2016-2021)
12.2 Global Prostacyclin Analogs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Prostacyclin Analogs Production Forecast by Type (2016-2021)
12.4 Global Prostacyclin Analogs Consumption Forecast by Application (2016-2021)
12.5 Prostacyclin Analogs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Prostacyclin Analogs
Figure Global Production Market Share of Prostacyclin Analogs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Prostacyclin Analogs Consumption Market Share by Application in 2015
Figure Health care Examples
Figure Clinic Examples
Figure Hospital Examples
Figure North America Prostacyclin Analogs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Prostacyclin Analogs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Prostacyclin Analogs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Prostacyclin Analogs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Prostacyclin Analogs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Prostacyclin Analogs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Prostacyclin Analogs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Prostacyclin Analogs Production of Key Manufacturers (2015 and 2016)
Table Global Prostacyclin Analogs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Prostacyclin Analogs Production Share by Manufacturers
Figure 2016 Prostacyclin Analogs Production Share by Manufacturers
Table Global Prostacyclin Analogs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Prostacyclin Analogs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Prostacyclin Analogs Revenue Share by Manufacturers
Table 2016 Global Prostacyclin Analogs Revenue Share by Manufacturers
Table Global Market Prostacyclin Analogs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Prostacyclin Analogs Average Price of Key Manufacturers in 2015
Table Manufacturers Prostacyclin Analogs Manufacturing Base Distribution and Sales Area
Table Manufacturers Prostacyclin Analogs Product Type
Figure Prostacyclin Analogs Market Share of Top 3 Manufacturers
Figure Prostacyclin Analogs Market Share of Top 5 Manufacturers
Table Global Prostacyclin Analogs Production by Regions (2011-2016)
Figure Global Prostacyclin Analogs Production and Market Share by Regions (2011-2016)
Figure Global Prostacyclin Analogs Production Market Share by Regions (2011-2016)
Figure 2015 Global Prostacyclin Analogs Production Market Share by Regions
Table Global Prostacyclin Analogs Revenue by Regions (2011-2016)
Table Global Prostacyclin Analogs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Prostacyclin Analogs Revenue Market Share by Regions
Table Global Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Prostacyclin Analogs Consumption Market by Regions (2011-2016)
Table Global Prostacyclin Analogs Consumption Market Share by Regions (2011-2016)
Figure Global Prostacyclin Analogs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Prostacyclin Analogs Consumption Market Share by Regions
Table North America Prostacyclin Analogs Production, Consumption, Import & Export (2011-2016)
Table Europe Prostacyclin Analogs Production, Consumption, Import & Export (2011-2016)
Table China Prostacyclin Analogs Production, Consumption, Import & Export (2011-2016)
Table Japan Prostacyclin Analogs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Prostacyclin Analogs Production, Consumption, Import & Export (2011-2016)
Table India Prostacyclin Analogs Production, Consumption, Import & Export (2011-2016)
Table Global Prostacyclin Analogs Production by Type (2011-2016)
Table Global Prostacyclin Analogs Production Share by Type (2011-2016)
Figure Production Market Share of Prostacyclin Analogs by Type (2011-2016)
Figure 2015 Production Market Share of Prostacyclin Analogs by Type
Table Global Prostacyclin Analogs Revenue by Type (2011-2016)
Table Global Prostacyclin Analogs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Prostacyclin Analogs by Type (2011-2016)
Figure 2015 Revenue Market Share of Prostacyclin Analogs by Type
Table Global Prostacyclin Analogs Price by Type (2011-2016)
Figure Global Prostacyclin Analogs Production Growth by Type (2011-2016)
Table Global Prostacyclin Analogs Consumption by Application (2011-2016)
Table Global Prostacyclin Analogs Consumption Market Share by Application (2011-2016)
Figure Global Prostacyclin Analogs Consumption Market Share by Application in 2015
Table Global Prostacyclin Analogs Consumption Growth Rate by Application (2011-2016)
Figure Global Prostacyclin Analogs Consumption Growth Rate by Application (2011-2016)
Table Actelion Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actelion Pharmaceuticals Ltd. Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Actelion Pharmaceuticals Ltd. Prostacyclin Analogs Market Share (2011-2016)
Table United Therapeutics Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table United Therapeutics Corporation Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Figure United Therapeutics Corporation Prostacyclin Analogs Market Share (2011-2016)
Table Gilead sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead sciences Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Gilead sciences Prostacyclin Analogs Market Share (2011-2016)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer AG Prostacyclin Analogs Market Share (2011-2016)
Table SteadyMed Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SteadyMed Ltd. Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Figure SteadyMed Ltd. Prostacyclin Analogs Market Share (2011-2016)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline plc Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline plc Prostacyclin Analogs Market Share (2011-2016)
Table Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc. Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. Prostacyclin Analogs Market Share (2011-2016)
Table Reata Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Reata Pharmaceuticals Inc. Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Reata Pharmaceuticals Inc. Prostacyclin Analogs Market Share (2011-2016)
Table Arena Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arena Pharmaceuticals Inc. Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Arena Pharmaceuticals Inc. Prostacyclin Analogs Market Share (2011-2016)
Table Merck & Co. Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Inc Prostacyclin Analogs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. Inc Prostacyclin Analogs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostacyclin Analogs
Figure Manufacturing Process Analysis of Prostacyclin Analogs
Figure Prostacyclin Analogs Industrial Chain Analysis
Table Raw Materials Sources of Prostacyclin Analogs Major Manufacturers in 2015
Table Major Buyers of Prostacyclin Analogs
Table Distributors/Traders List
Figure Global Prostacyclin Analogs Production and Growth Rate Forecast (2016-2021)
Figure Global Prostacyclin Analogs Revenue and Growth Rate Forecast (2016-2021)
Table Global Prostacyclin Analogs Production Forecast by Regions (2016-2021)
Table Global Prostacyclin Analogs Consumption Forecast by Regions (2016-2021)
Table Global Prostacyclin Analogs Production Forecast by Type (2016-2021)
Table Global Prostacyclin Analogs Consumption Forecast by Application (2016-2021)


More Publications